Transient Abnormal Myelopoiesis in Down's Syndrome

References

• Miller R. W. Persons with exceptionally high risk of leukemia. Cancer Research 1967; 27: 2420–2423
   PubMed Web of Science ®Google Scholar
• Miller R. W. Neoplasia and Down's syndrome. Ann New York Academy of Sciences 1970; 171: 637–644
   Web of Science ®Google Scholar
• Lahey M. E., Beier F. R., Wilson J. F. Leukemia in Down's syndrome. Journal of Pediatrics 1963; 63: 189–190
   PubMed Web of Science ®Google Scholar
• Okada H., Lin P. I., Hoshino T., Yamamoto Y., Yamaoka H., Murakami M. Down's syndrome associated with a myeloproliferative disorder. American Journal of Diseases of Children 1972; 124: 107–110
   PubMedGoogle Scholar
• Fong C. T., Brodeur G. M. Down's syndrome and leukemia: Epidemiology, genetics, cytogenetics and mechanisms of leukemogenesis. Cancer Genetics and Cytogenetics 1987; 28: 55–76
   PubMed Web of Science ®Google Scholar
• Schunk G. J., Lehman W. L. Mongolism and congenital leukemia. Journal of the American Medical Association 1954; 155: 250–251
   PubMed Web of Science ®Google Scholar
• Engel R. R., Hammond D., Eitzman D. V., Pearson H., Krivet W. Transient congenital leukemia in 7 infants with mongolism. Journal of Pediatrics 1964; 65: 303–306
   PubMed Web of Science ®Google Scholar
• Wigelius R., Vaananen I., Koslela S. L. Down's syndrome and transient leukemia-like disease in a newborn. Acta Paediactrica Scandinavica 1967; 56: 301–306
   PubMed Web of Science ®Google Scholar
• Lin H. P., Menaka H., Lim K. H., Young H. S. Congenital leukemoid reaction followed by fatal leukemia. American Journal of Diseases of Children 1980; 134: 939, 941.
   PubMedGoogle Scholar
• Vesterhus P., Moe P. J. Bone marrow dysfunction in a newborn twin with Down's syndrome: Report of a transitory leukemia-like blood reaction. Clinical Pediatrics 1974; 13: 347–349
   PubMed Web of Science ®Google Scholar
• Mutz D., Urban ChE. Pseudoleukemia bei einem Neugeborenen mit Trisomie 21. Helv Paediatrica Acta 1976; 31: 515–520
   Google Scholar
• Nagao T., Lampkin B. C., Hug G. A neonate with Down's syndrome and transient abnormal myelopoiesis: Serial blood and bone marrow studies. Blood 1970; 36: 443–447
   PubMed Web of Science ®Google Scholar
• Shinbo T., Nagao T., Kimura S., et al. Six cases of Down's syndrome with leukemia-like blood picture. Leukemia and transient abnormal myelopoiesis (TAM). Japanese Journal of Clinical Hematology 1977; 18: 99–109
   PubMedGoogle Scholar
• Pochedly C., Ente G. Disseminated intravascular coagulation in a newborn with Down's syndrome. Journal of Pediatrics 1968; 73: 298
   PubMed Web of Science ®Google Scholar
• Cosson A., Despres P., Gazengel C., Breton-Gorius J., Prieur M., Josso F. Unusual leukemic syndrome in newborn trisomy 21: Megakaryocyte and platelet proliferation with diffuse intravascular coagulation. Nouvelle Revue Francaise D'Hematologie 1974; 14: 181–198
   PubMedGoogle Scholar
• Miller J. M., Sherrill J. G., Hathaway W. E. Thrombocythemia in the myeloproliferative disorder of Down's syndrome. Pediatrics 1967; 40: 847–850
   PubMed Web of Science ®Google Scholar
• Nakagawa T., Nishida H., Arai T., Yamada T., Fukuda M., Sakamoto S. Hyperviscosity syndrome with transient abnormal myelopoiesis in Down syndrome. Journal of Pediatrics 1988; 112: 58–61
   PubMed Web of Science ®Google Scholar
• Barak Y., Mogilner B. M., Karov Y., Nir E., Schlesinger M., Levin S. Transient acute leukemia in a newborn with Down's syndrome: Prediction of its reversibility by bone marrow cultures. Acta Paediactrica Scandinavica 1982; 71: 699–701
   PubMed Web of Science ®Google Scholar
• Denegri J. F., Rogers P. C. X., Chan K. W., Sadoway J., Thomas J. W. In vitro cell growth in neonates with Down's syndrome and transient myeloproliferative disorder. Blood 1981; 58: 675–677
   PubMed Web of Science ®Google Scholar
• Alarcon P., Patil S., Golberg J., Allen J. B., Shaw S. Infants with Down's syndrome: Use of cytogenetic studies and in vitro colony assay for granulocyte progenitor to distinguish acute nonlymphocytic leukemia from a transient myeloproliferative disorder. Cancer 1987; 60: 987–993
   PubMed Web of Science ®Google Scholar
• Rogers P. C. J., Denegri J. F., Thomas J. W., Kalousek D., Gillen J., Baker M. A. Down syndrome leukemia vs. pseudoleukemia. Blood 1978, St(suppl I), 273.
   Google Scholar
• Rogers P. C. J., Thomas J. W., Kalousek D. K., Baker M. A., Denegri J. F. Neonate with Down's syndrome and transient congenital leukemia: In vitro studies. American Journal of Pediatric Hematolology and Oncology 1983; 5: 59–64
   PubMedGoogle Scholar
• Liang D. C., Shen E. Y., Chyou S. C. To early distinguish neonatal transient leukemoid proliferation from congenital leukemia by in vitro cell growth. Blut 1986; 53: 101–106
   PubMedGoogle Scholar
• Mendelow B., Krawitz S., Cohn R., Bernstein R. “Leukemic” pattern of in vitro growth in a patient with Down syndrome and transient myeloproliferative disorder. American Journal of Hematolology 1984; 16: 293–296
   PubMed Web of Science ®Google Scholar
• Zipursky A., Peeters M., Poon A. Megakaryoblas-tic leukemia and Down's syndrome. A review. Pediatric Hematology and Oncology 1987; 4: 211–230
   PubMed Web of Science ®Google Scholar
• Tsuda T., Komiyama A., Aonuma K., Akabane T., Nakayama M. Transient abnormal myelopoiesis and diffuse hepatic necrosis in Down's syndrome with prominent bleeding diathesis. Acta Paediatrica Scandinavica 1990; 79: 241–244
   PubMed Web of Science ®Google Scholar
• Toyoda Y., Tonouchi T., Mimaya J., Hamazaki M., Hujiwara S., Hayashi Y., Eguchi M., Sugita K. An autopsy case of transient abnormal myelopoiesis: Evidence of megekaryocytic differentiation of blast cells in vivo. Japanese Journal of Clinical Hematology 1987; 28: 2039, 2044.
   PubMedGoogle Scholar
• Conen A., Erkman B. Combined mongolism and leukemia: Report of eight cases with chromosome studies. American Journal of Diseases of Children 1966; 112: 429–443
   PubMedGoogle Scholar
• Honda F., Punnett H. H., Charney E., Miller G., Thiede H. A. Serial cytogenetic and hematologic studies on a mongol with trisomy 21 and acute congenital leukemia. Journal of Pediatrics 1964; 65: 880–887
   PubMed Web of Science ®Google Scholar
• Lewis D. S., Thompson M., Hudson E., Liberman M. M., Samson D. Down's syndrome and acute megakaryoblastic leukemia. Acta Haematologica 1983; 70: 236–242
   PubMed Web of Science ®Google Scholar
• Yokoyama S., Nito T., Irimada K., Yoshimura Y., Hayashi T. Acute megakaryoblastic leukemia pre-ceeded by refractory anemia with an excess of blast cells: Leukemic transformation in an infant of Down syndrome recovering from transient abnormal myelopoiesis. Acta Haematology of Japan 1984; 47: 62–70
   PubMed Web of Science ®Google Scholar
• Barnett P. L. J., Clark A. C. L., Carson O. M. Acute nonlymphocytic leukemia after transient myeloproli-ferative disorder in a patient with Down syndrome. Medical and Pediatric Oncology 1990; 18: 347–353
   PubMedGoogle Scholar
• Ross J. D., Moloney W. C., Desforges J. F. Ineffective regulation of granulopoiesis masquerading as congenital leukemia in a mongoloid child. Journal of Pediatrics 1963; 63: 1–10
   PubMed Web of Science ®Google Scholar
• Lobato-Mendizabal E., Marin-Lopez A., Lopez-De-La-Cruz G., Presno-Bernal M., Ruiz-Arguelles G. J. Congenital acute megakaryoblastic leukemia in Down's syndrome. Leukemia and Lymphoma 1990; 2: 137–139
   PubMedGoogle Scholar
• Coulombel L., Derycke M., Villeval J. L., Leonard C., Breton-Gorius J., Vial M., Bourgeois P., Tchernia G. Characterization of the blast cell population in two neonetes with Down's syndrome and transient myeloprolifera-tive disorder. British Journal of Hematology 1986; 66: 69–76
   Web of Science ®Google Scholar
• Lazarus K. H., Heerema N. A., Palmer C. G., Baehner R. L. The myeloproliferative reaction in a child with Down's syndrome: Cytological and chromosomal evidence for a transient leukemia. American Journal of Hematology 1981; 11: 417–423
   PubMed Web of Science ®Google Scholar
• Adams R. H., Lemons R. S., Thangavelu M., Beau M. M., Robert D. C. Interstitial deletion of chromosome 5, del(5q), in a newborn with Down syndrome and an unusual hematologic disorder. American Journal of Hematology 1989; 31: 273–279
   PubMed Web of Science ®Google Scholar
• Domenico D. R., Dizike G. J., Melnyk A. R., Bird M. L., Suarez C. R., Schumacher H. R. Pseudoleukemia in Down's syndrome: Analysis of immunophenotype and gene rearrangement. American Journal of Clinical Pathology 1988; 91: 709–714
   Web of Science ®Google Scholar
• Suda J., Eguchi M., Akiyama Y., Iwama Y., Furukawa T., Sato Y., Miura Y., Suda T., Saito M. Differentiation of blast cells from a Down's syndrome patient with transient myeloproliferative disorder. Blood 1987; 69: 508–512
   PubMed Web of Science ®Google Scholar
• Miyashita T., Asada M., Fujimoto J., Inaba T., Takihara Y., Sugita K., Bessho F., Furukawa T., Mitzutani S. Clonal analysis of transient myeloproliferative disorder in Down's syndrome. Leukemia 1991; 5: 56–59
   PubMed Web of Science ®Google Scholar
• Mizutani S., Miyashita T., Nakamura K., Asada M., Zhong W. K., Tamura K. Molecular studies on childhood hematological malignancies. The Second International symposium on children's cancer. Present problems and future prospects, Childhood leukemia 1989; 43, Japan, 1989)
   Google Scholar
• Kurahashi H., Hara J., Yumura-Yagi K., Murayama N., Inoue M., Ishihara S., Tawa A., Okada S., Kawa-Ha K. Monoclonal nature of transient abnormal myelopoiesis in Down's syndrome. Blood 1991; 77: 1161–1163
   PubMed Web of Science ®Google Scholar
• Vogelstein B., Fearon E. R., Hamilton S. R., Feinberg A. P. Use of restriction fragment length polymorphisms to determine the clonal origin of human tumors. Science 1985; 227: 642–646
   PubMed Web of Science ®Google Scholar
• Vogelstein B., Fearon E. R., Hamilton S. R., Preisinger S. C., Willard H. F., Michelson A. M., Riggs A. D., Orkin S. H. Clonal analysis using recombinant DNA probes from the X-chromosome. Cancer Research 1987; 47: 4806–4811
   PubMed Web of Science ®Google Scholar
• Rosner F., Lee S. L. Down's syndrome and acute leukemia: Myeloblastic or lymphoblastic. American Journal of Medicine 1972; 53: 203–218
   PubMed Web of Science ®Google Scholar
• Cook J. A., Raney J. B., Innes J. D. J., Normansell D. Transient myeloproliferative disorder: In a neonate with Down syndrome. Immunophenotypic studies. Clinical Pediatrics 1989; 28: 132–135
   PubMed Web of Science ®Google Scholar
• Castro M. F., Salas S., Martinez A., Larrocha C., Viloria A., Jimenez M. C. Transitory T-lymphoblastic leukemoid reaction in a neonate with Down syndrome. American Journal of Pediatric Hematology and Oncology 1990; 12: 71–73
   PubMedGoogle Scholar
• Von Boros J., Korenyi A. Uber eienen Fall von akuter megakaryoblasten Leukeamie: Zugleich einige Be-merkungen zum Problem der akuten Leukemie. Zei tschrift fur Klinische Medizim, ZKM 1931; 118: 697
   Google Scholar
• Breton-Gorius J., Guichard J. Ultrastructural localization of peroxidase activity in human platelets and megakaryocytes. American Journal of Pathology 1972; 66: 277
   PubMed Web of Science ®Google Scholar
• Bennett J. M., Catovsky D., Daniel M. T., Flandrin G., Galton D. A. G., Gralnick H. R., Sultan C. Criteria for the diagnosis of acture leukemia of megakaryoctye lineage (M7): A report of the French-American-British cooperative group. Annals of Internal Medicine 1985; 103: 460–462
   PubMed Web of Science ®Google Scholar
• Koike T. Megakaryoblastic leukemia: The characterization and identification of megakaryoblasts. Blood 1984; 64: 683–692
   PubMed Web of Science ®Google Scholar
• Koike T., Aoki S., Maruyama S., Narita M., Ishizuka T., Imanaka H., Adachi T., Maeda H., Shibata A. Cell surface phenotyping of megakaryoblasts. Blood 1987; 69: 957–960
   PubMed Web of Science ®Google Scholar
• Hayashi Y., Hanada R., Yamamoto K., Ohde S., Niitsu N., Eguchi M., Sugita K., Nakazawa S. Transient megakaryoblastic proliferation in a newborn infant with Down's syndrome. Cancer Genetics and Cytogenerics 1987; 28: 373–374
   PubMed Web of Science ®Google Scholar
• Shibata A., Koike T., Aoki S., Maruyama S., Ishizuka T., Otsuka T. Characterization of proliferating cells in transient abnormal myelopoiesis: Ultrastructural and immu-nocytochemical study. Keio Journal of Medicine (Japan 1987; 36: 62–66
   PubMedGoogle Scholar
• Yumura-Yagi K., Hara J., Kurahashi H., Nishimura T., Kaneyama Y., Osugi Y., Sakata N., Inoue M., Tawa A., Okada S., Kawa-Ha K. Mixed phenotype of blasts in acute megakaryocytic leukemia and transient abnormal mylopoiesis in Down's syndrome. British Journal of Haematology. 1992, in press).
   Google Scholar
• Bessho F., Hayashi Y., Hayashi Y., Ohga K. Ultrastructural studies of peripheral blood of neonates with Down's syndrome and transient abnormal myelopoiesis. American Journal of Clinical Pathology 1988; 89: 627–633
   PubMed Web of Science ®Google Scholar
• Eguchi M., Sakakibara H., Suda J., Ozawa T., Hayashi Y., Sato T., Kojima S., Furukawa T. Ultrastructural and ultracytochemical differences between transient myeloproliferative disorder and megekeryoblastic leukemia in Down's syndrome. British Journal of Hematology 1989; 73: 315–322
   PubMed Web of Science ®Google Scholar
• Suda J., Eguchi M., Ozawa T., Furukawa T., Hayashi Y., Kojima S., Maeda H., Tadokoro K., Sato Y., Miura Y., Ohara A., Suda T. Platelet peroxidase-positive blast cells in transient myeloproliferative disorder with Down's syndrome. British Journal of Hematology 1988; 68: 181–187
   PubMed Web of Science ®Google Scholar
• Suda T., Suda J., Miura Y., Hayashi Y., Eguchi M., Tadokoro K., Saito M. Clonal analysis of basophil differentiation in bone marrow cultures from a Down's syndrome patient with megakaryoblastic leukemia. Blood 1985; 66: 1278–1283
   PubMed Web of Science ®Google Scholar
• Koike T., Urushiyama M., Narita M., Saito H., Ishida F., Imashuka S., Morioka Y., Utsumi J., Lshizuka T., Tsuruta T., Takeuchi Y., Kashimura M., Shibata A. Target cell of leukemic transformation in acute megakaryoblastic leukemia. American Journal of Hematology 1990; 34: 252–258
   PubMed Web of Science ®Google Scholar
• Fraser J. K., Leahy M. F., Berridge M. V. Expression of antigens of the platelet glycoprotein 2b/3a complex on human hematopoietic stem cells. Blood 1986; 68: 762–769
   PubMed Web of Science ®Google Scholar
• Polli N., O'Brien N., Tarvares C. J., Matutes E., San Miguel J. F., Catovsky D. Characterization of blast cells in chronic granulocytic leukemia in transformation, acute myelofibrosis and undifferentiated leukemia. British Journal of Hematology 1985; 59: 277–296
   PubMed Web of Science ®Google Scholar
• Abe K., Kajii T., Niikawa N. Disomic homozygosity in 21-trisomic cells: A mechanism responsible for transient myeloproliferative syndrome. Human Genetics 1989; 82: 313–316
   PubMed Web of Science ®Google Scholar
• Van Den Berghe H., Vermaelen K., Orshoven J. B., Delbeke M. J., Benoit Y., Orye E., Van Eygen M., Logghe N. Pentasomy 21 characterizing spontaneously regressing acute leukemia. Cancer Genetics and Cytogenetics 1983; 9: 19–24
   PubMed Web of Science ®Google Scholar
• Brothman A. R., Ghosn C., Werner E. Pentasomy 21q in a neonatal case of acute myeloblastic leukemia. Cancer Genetics and Cytogenetics 1990; 47: 135–137
   PubMed Web of Science ®Google Scholar
• Brodeur G. M., Dahl G. V., Williams D. L., Tipton R. E., Kalwinsky D. K. Transient leukemoid reaction and trisomy 21 mosaicism in a phenotypically normal newborn. Blood 1980; 55: 691–693
   PubMed Web of Science ®Google Scholar
• Heaton D. C., Fitzgerald P. H., Fraser G. J., Abbott G. D. Transient leukemoid proliferation of the cytogenetic-ally unbalanced +21 cell line of a constitutional mosaic boy. Blood 1981; 57: 883–887
   PubMed Web of Science ®Google Scholar
• Weinberg A. G., Schiller G., Windmiller J. Neonatal leukemoid reaction: An isolated manifestation of mosaic trisomy 21. American Journal of Diseases of Children 1982; 136: 310–311
   PubMedGoogle Scholar
• Seibel N. L., Sommer A., Miser J. Transient neonatal leukemoid reaction in mosaic trisomy 21. Journal of Pediatrics 1984; 104: 251–254
   PubMed Web of Science ®Google Scholar
• Hanna M. D., Melvin S. L., Dow L. W. Transient myeloproliferative syndrome in a phenotypically normal infant. American Journal of Pediatric Hematology and Oncology 1985; 7: 79–81
   PubMedGoogle Scholar
• Jones G. R., Weaver M., Laug W. E. Transient blastemia in phenotypically normal newborns. American Journal of Pediatric Hematology and Oncology 1987; 9: 153–157
   PubMedGoogle Scholar
• Kalousek D. K., Chan K. W. Transient myeloproliferative disorder in chromosomally normal newborn infant. Medical Pediatric Oncology 1987; 15: 38–41
   PubMedGoogle Scholar
• Ridgway D., Benda G. I., Magenis E., Allen L., Segal G. M., Braziel R. M., Neerhout R. C. Transient Myeloproliferative Disorder of the Down type in the normal newborn. American Journal of Diseases of Children 1990; 144: 1117–1119
   PubMedGoogle Scholar
• Fead M. J. W., Robertson J., Todd A. S., Sivakumaran M., Tarnow-Mordi W. O. Trisomy 21 in transient myeloproliferative disorder. Cancer Genetics and Cytogenetics 1990; 48: 259–264
   PubMed Web of Science ®Google Scholar
• Cairney A. E. L., McKenna R., Arthur D. C., Nesbit M. E., Woods W. G. Acute megakaryoblastic leukemia in children. British Journal of Haematology 1986; 63: 541–554
   PubMed Web of Science ®Google Scholar
• Chan W. C., Brynes R. K., Kim T. H., Verras A., Schick C., Green R. J., Ragab A. H. Acute megakaryoblastic leukemia in early childhood. Blood 1983; 62: 92–98
   PubMed Web of Science ®Google Scholar
• Sariban E., Oliver C., Corash L., Cossman J., Whang-Peng J., Jaffe E. S., Gralnick H. R., Poplack D. G. Acute megakaryoblastic leukemia in childhood. Cancer 1984; 54: 1423–1428
   PubMed Web of Science ®Google Scholar
• Pui C.-H., Rivera G., Mirro J., Stass S., Peiper S., Murphy S. B. Acute megakaryoblastic leukemia. Archives of Pathology & Laboratory Medicine 1985; 109: 1033
   PubMed Web of Science ®Google Scholar
• Simon J. H., Tebbi C. K., Freeman A. I., Brecher M. L., Green D. M., Sandberg A. A. Acute mega karyoblastic leukemia associated with mosaic Down's syndrome. Cancer 1987; 60: 2515–2520
   PubMed Web of Science ®Google Scholar
• Cuneo A., Mecuccu C., Kerim S., Vandenberghe E., Dal Cin P., Van Orshoven A., Rodhain J., Bosly A., Michaux J. L., Martiat P., Boogaerts M., Carli M. G., Castoldi G., Van Den Berghe H. Multipotent stem cell involvement in megakaryoblastic leukemia: Cytologic and cytogenetic evidence in 15 patients. Blood 1989; 74: 1781–1790
   PubMed Web of Science ®Google Scholar
• Arico M. Acute megakaryoblastic leukemia and clonal trisomy 21 in a phenotypically normal infant. Blood 1991; 77: 542–2543
   PubMedGoogle Scholar
• Johansson B., Mertens F., Heim S., Kristoffersson U., Mandahl N., Nilsson P. G., Mitelman F. Cytogenetici findings in acute magakaryoblastic leukemia (ANLL-M7). Cancer Genetics and Cytogenetics 1990; 48: 119–123
   PubMed Web of Science ®Google Scholar
• Pui C.-H., Williams D. L., Scarborough V., Jackson C. W., Price R., Murphy S. Acute megakaryoblastic leukemia associated with intinsic platelet dysfunction and constitutional ring 21 chromosome in a young boy. British Journal of Haematology 1982; 50: 191
   PubMed Web of Science ®Google Scholar
• Sansone R., Pierluigi M., Carobbi S., Cominetti M., Stringini P. Disomic homozygosity annd leukemia in Down's syndrome. Human Genetics 1990; 85: 386
   PubMed Web of Science ®Google Scholar
• Sunami S., Fuse A., Simizu B., Eguchi M., Hayashi Y., Sugita K., Nakazawa S., Okimoto Y., Sata T., Nakajima H. The c-sis gene expression in cells from a patient with acute megakaryoblastic leukemia and Down's syndrome. Blood 1987; 70: 368–371
   PubMed Web of Science ®Google Scholar
• Ross R., Raines E. W., Bowen P. D. F. The biology of platelet-derived growth factor. Cell 1986; 46: 155–169
   PubMed Web of Science ®Google Scholar
• Zipursky A., Peeters M., Poon A., Edited By McCoy E. E., Epstein C. J. Megakaryoblastic leukemia and Down's syndrome. A review. In Oncology and immunology of Down's syndrome. Alan R. Liss, New York 1986; 33–56
   Google Scholar
• Stiller C. A., Kinnier-Wilson L. M. Down syndrome and leukemia. Lancet 1981; 2: 1343
   PubMed Web of Science ®Google Scholar
• Kojima S., Matsuyama T., Sato T., et al. Down's syndrome and acute leukemia in children: An analysis of phenotype by use of monoclonal antibodies and electron microscopic platelet peroxidase reaction. Blood 1990; 76: 2348–2353
   PubMed Web of Science ®Google Scholar
• Lewis D. S. Association between megakaryoblastic leukemia and Down syndrome. Lancet 1981; 2: 695
   PubMed Web of Science ®Google Scholar
• Hayashi Y., Eguchi M., Sugita K., Nakazawa S., Sato T., Kojima S., Bessho F., Konishi S., Inaba T., Hanada R., Yamamoto K. Cytogenetic findings and clinical features in acute leukemia and transient myeloproliferative disorder in Down's syndrome. Blood 1988; 72: 15–23
   PubMed Web of Science ®Google Scholar
• Nito T., Terashima K., Matsuda M., Imai Y., Yokoyama S., Hayashi T. Transient abnormal myelopoiesis followed by acute megakaryoblastic leukemia with extra medullary tumors: An autopsied case of Down's syndrome. Acta Pathology of Japan 1983; 33: 1027–1039
   PubMedGoogle Scholar
• Ueda K., Kawaguchi Y., Kodama M., Tanaka Y., Usui T., Kameda N. Primary myelofibrosis with myeloid metaplasia and cytogenetically abnormal clones in two children with Down's syndrome. Scandinavian Journal of Hematology 1981; 27: 152–158
   PubMedGoogle Scholar
• Kaneko Y., Rowley J. D., Variakojis D., Chilcote R. R., Moohr J. W., Petel D. Chromosome abnormalities in Down's syndrome patients with acute leukemia. Blood 1981; 58: 459–466
   PubMed Web of Science ®Google Scholar
• Srivastava A. K., Wong K. Y. Trisomy 7, monosomy 17, and tetrasomy 21 in a Down syndrome patient with acute nonlymphocutic leukemia. American Journal of Human Genetics 1984; 36(suppl)385
   Google Scholar
• Morgan R., Hecht F., Cleary M. L., Sklar J., Link M. P. Leukemia with Down's syndrome: Translocation between chromosomes I and 19 in acute myelomonocytic leukemia following transient congenital myeloproliferative syndrome. Blood 1985; 66: 1466–1468
   PubMed Web of Science ®Google Scholar
• Suarez C. R., Le Beau M. M., Silberman S., Fresco R., Rowley J. D. Acute megakaryoblastic leukemia in Down's syndrome: Report of a case and review of cytogenetic findings. Medical and Pediatric Oncology 1985; 13: 225–231
   PubMedGoogle Scholar
• Ferster A., Verhest A., Vamos E., Maertelaere E., Otten J. Cancer Genetics and Cytogenetics 1986; 20: 109–113
   PubMed Web of Science ®Google Scholar
• Wong K. Y., Jones M. M., Strivastava A. K., Gruppo R. A. Transient myeloproliferative disorder and acute nonlymphoblastic leukemia in Down syndrome. Journal of Pediatrics 1988; 112: 18–22
   PubMed Web of Science ®Google Scholar
• Jiang C. J., Liang D. C., Tien H. F. Neonatal transiedt leukaemoid proliferation followed by acute myeloid leukemia in a phenotypically normal child. British Journal of Haematology 1991; 77: 247–248
   PubMed Web of Science ®Google Scholar
• Fearon E. R., Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 1990; 61: 759–767
   PubMed Web of Science ®Google Scholar
• Heidemann A., Schmalenberger B., Zankel H. SCE frequency and lymphocyte proliferation in a Down's syndrome mosaic developing an acute lymphoblastic leukemia. Cancer Genetics and Cytogenetics 1985; 15: 109–112
   PubMed Web of Science ®Google Scholar